Skip to Main Content

Paper Details

TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer.
1
2023
DDR Gene, Enzalutamide, HRR, HRR gene, Men, PARP, Poly(ADP-ribose), Poly(ADP-ribose) polymerase, Talazoparib, androgen, castration-, enzalutamide, homologous recombination repair, homologous recombination repair (HRR) gene, mCSPC, metastatic castration-sensitive prostate cancer, patients, sensitive prostate cancer, talazoparib
Author NameAffiliation
Neeraj AgarwalHuntsman Cancer Institute, University of Utah
  • 1 - 1

Datasets

Release 1.2